Abstract
Abnormal CCND1 expression is found in the majority of mantle cell lymphomas (MCL) and in a minority of other mature B cell malignancies. Its evaluation can therefore aid diagnostic classification, in conjunction with clinical, morphological, immunophenotypic and cytogenetic analysis. We describe a rapid slot-blot hybridization technique allowing quantitative assessment of CCND1 expression relative to β-actin, with a sensitivity cut-off of approximately 10%. This allowed clear separation (P < 0.01) of ccnd1 mcl (0.89 ± 0.4; range 0.23–1.81; n = 25) from control samples (0.02 ± 0.04; range 0–0.09; n = 22) on limited quantities of RNA (1–3.5 μg). Of nine samples in which a potential diagnosis of MCL lymphoma was based on morphological analysis of paraffin-embedded material, without adequate immunophenotype analysis, all were CCND1 negative and subsequent immunophenotype demonstrated features compatible with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) (CD5+, CD23+, FMC7−) in all cases tested. This study demonstrates the feasibility of slot-blot CCND1 quantification and the importance of the availability of cryopreserved material.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mauvieux, L., Canioni, D., Hermine, O. et al. Quantitative RNA slot-blot analysis of CCND1/cyclin D1 expression in suspected mantle cell lymphoma. Leukemia 12, 78–85 (1998). https://doi.org/10.1038/sj.leu.2400884
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400884
Keywords
This article is cited by
-
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study
Leukemia (2002)
-
Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype
Leukemia (2001)
-
Blastic Mantle Cell Leukemia: An Unusual Presentation of Blastic Mantle Cell Lymphoma
Modern Pathology (2000)